Tarik Möröy

Since 2006, Tarik Möröy, PhD, is the President and Scientific Director of the Montreal Clinical Research Institute/Institut de recherches cliniques de Montréal (IRCM), as well as Director of the Hematopoiesis and Cancer research unit and Full IRCM Research Professor. Since 2007, he holds the Canada Research Chair (Tier 1) in Hematopoiesis and Immune Cell Differentiation. He is also Full Research Professor at the Université de Montréal and adjunct professor at McGill University. He is also President of the Canadian Society for Molecular Biosciences Since his academic accreditation in 1991 in Germany, he has trained over 50 postdoctoral fellows and graduate students, directed several research networks and, until 2006, held several senior management positions in Germany. As the IRCM’s President and Scientific Director, he provides leadership for 36 principal investigators. He is responsible for strategic planning; recruitment of researchers and clinician scientists (17 new researcher professors and 6 new directors of specialized research clinics were recruited or nominated since 2007); the institute’s funding; university, hospital and government relations; training, public communications and education; operations of the IRCM clinic; and overseeing the budget of one of Canada’s leading biomedical research institutions. Under his management, the IRCM vastly expanded its technical core facilities services and created a graduate program focused on translational research in order to bridge the gap between basic laboratory research and the needs of the clinical practice, thus accelerating the shift towards personalized medicine. He presently leads the two major initiatives of the IRCM Strategic Plan on the Research Centre on Rare and Genetic Diseases in Adults and the establishment of a pipeline for the production of biomarkers. These actions centered around the desire to “provide passionate researchers with the ideal conditions to experiment with their boldest ideas, test their theories and pave their own way for the benefit of us all”. Dr. Möröy has authored more than 300 publications, including 163 original articles and reviews in specialized journals, as well as over 140 contributions to scientific meetings. In 2014, he received a recognition award from the Leukemia and Lymphoma Society. He was also appointed “Honorary Guest Professor” by the Capital University in Beijing for his outstanding achievements in immunology in 2015. He is an active member of the M8 Alliance and co-organizer of the 2017 World Health Summit Regional Meeting in Montreal, Canada. He was elected to the Board of Directors of the Canadian Society for Molecular Biosciences in 2015, Vice president in 2017 and President in 2018. He is serving on the Board of Directors of Research Canada since 2016 and has been appointed member of the College of Reviewers for the Canadian Institutes of Health Research in 2017. Dr. Möröy has been elected fellow of the Canadian Academy of Health Sciences in 2018. For more information, please visit https://ircm.qc.ca/en/institute/message-from-the-president and his lab site at http://www.moroylab.org/.